Technologies for a Free and Healthy Life
Freedom Meditech spacer bar

News

Freedom Meditech Receives FDA 510(k) Clearance for ClearPath DS-120TM
Published Tuesday, February 12, 2013

SAN DIEGO, CA (February 12, 2013) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell its first product, the ClearPath DS-120TM Lens Fluorescence Biomicroscope.

more»


Freedom Meditech Secures $2 Million in Funding from Silicon Valley Bank
Published Thursday, September 27, 2012
SAN DIEGO, CA (September 27, 2012) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has secured a $2 million line of credit from Silicon Valley Bank (SVB). The funds will be used to ramp up manufacturing and distribution of the company's ClearPath more»


Freedom Meditech Submits 510(k) Application with FDA for First Product
Published Thursday, October 13, 2011
SAN DIEGO, CA (October 13, 2011) – Freedom Meditech, Inc., developer of non-invasive ophthalmic products for the detection of disease and management of patient health, today announced it has submitted a Premarket Notification 510(k) application with the U.S. Food and Drug administration (FDA) for the company's ClearPath DS-120™ Lens Fluorescence Biomicroscope. more»


Expanded Research Confirms Freedom Meditech Technology Accurately Monitors Glucose Non-Invasively in the Eye with Light
Published Thursday, March 10, 2011
TOLEDO, OHIO (March 10, 2011) – People with diabetes, who currently monitor their glucose with painful and inconvenient blood tests or implanted probes, could in the future, get the same results by rapidly shining a safe non-invasive light into their eye, according to results of a study published in the March issue of the Journal of Diabetes Science and more»


Non-invasive Glucose Measurements in the Eye Highly Effective in Clinical Study
Published Thursday, November 11, 2010
BETHESDA, MARYLAND (November 11, 2010) – Freedom Meditech, Inc., the developer of non-invasive, ophthalmic-based products to detect and manage diabetes, today announced results of a clinical study that showed a high correlation between blood glucose levels and non-invasive glucose measurements in the eye in a live animal model. Results of the study of more»


Initial Research Shows Glucose Levels May Be Measured Painlessly with Light in the Eye
Published Tuesday, October 13, 2009
PITTSBURGH, PA (October 13, 2009) – New non-invasive technology designed to painlessly measure glucose levels in the human eye shows promise of one day replacing the finger-stick blood test, according to results of a pre-clinical study funded by Freedom Meditech, Inc. The study, involving rabbits, showed that the eye-scanning technology produced more»


Deal Between Freedom Meditech and Battelle Could Lead to Breakthrough in Diabetes Management
Published Thursday, February 28, 2008
SAN DIEGO, CA AND COLUMBUS, OH (February 28, 2008) – Freedom Meditech, Inc., a developer of a proprietary non-invasive ocular glucose measurement technology for people with diabetes, today announced an agreement with Battelle to begin an initial phase of development for a device for use in Food and Drug Administration (FDA)-compliant pilot human clinical more»


Freedom Meditech Establishes Diabetes R&D Operations in Ohio
Published Tuesday, February 12, 2008
SAN DIEGO AND CLEVELAND (February 12, 2008) – Freedom Meditech, Inc. , a San Diego­based developer of a non­invasive ocular glucose measurement technology for people with diabetes, today announced the opening of new research and development (R&D) operations in Ohio. The new R&D operation leverages a product development services agreement with more»


Freedom Meditech Executes License for Non-Invasive Glucose Monitoring Technology for Diabetes
Published Tuesday, January 30, 2007
SAN DIEGO (January 30, 2007) – Freedom Meditech, Inc. today announced the consummation of an exclusive, royalty bearing, worldwide license for the continued development and commercialization of a patent-pending noninvasive ocular glucose measurement technology for use by people with diabetes. The consumer ready product will be the size of a pair of more»


Items 1-9 of 9